Literature DB >> 20494017

The 30- versus 90-day operative mortality after pulmonary resection.

Ayesha S Bryant1, Kyle Rudemiller, Robert J Cerfolio.   

Abstract

BACKGROUND: The 30-day operative mortality rate after thoracotomy is well documented; however, the 90-day mortality rate is not and is not part of The Society of Thoracic Surgeons database.
METHODS: We performed a retrospective cohort study using a prospective database of patients who underwent elective thoracotomy and pulmonary resection. Mortality rates were compared with The Society of Thoracic Surgeons database. Multivariate analysis was used to identify predictors of mortality after discharge but within 30 and 90 days.
RESULTS: There were 1,845 operative patients between January 2002 and December 2008. Mortality was defined several ways. The overall discharge mortality was 3.1%; however, 18 patients (1.0%) died after discharge within 30 days and 44 patients (2.5%) died between 31 and 90 days. Sudden death (usually because of a cardiac event) was the most common cause of death in patients after discharge before postoperative day 30 and the second most common cause in those who died after discharge between days 31 and 90. These patients were more likely to have advanced age (p = 0.004), history of hypertension (p = 0.013), and coronary artery disease (p < 0.001).
CONCLUSIONS: A significant number of patients die after discharge within 90 days after pulmonary resection. The most common causes of death at home are "sudden death" and are more common in patients with a history of coronary artery disease. These patients may benefit from more diligent postoperative care. A prospective database with calls to patients and families is required to accurately obtain this information and to establish true outcomes. The Society of Thoracic Surgeons database as well as nonsurgical databases that show efficacies of medical therapy for specific ailments should consider adding 90-day mortality results. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494017     DOI: 10.1016/j.athoracsur.2010.01.069

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard.

Authors:  Deniz Yalman; Ugur Selek
Journal:  Ann Transl Med       Date:  2015-07

3.  Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.

Authors:  Chad G Rusthoven; Brian D Kavanagh; Sana D Karam
Journal:  Ann Transl Med       Date:  2015-07

4.  Risk assessment of perioperative mortality after pulmonary resection in patients with primary lung cancer: the 30- or 90-day mortality.

Authors:  Kenji Tomizawa; Noriyasu Usami; Koichi Fukumoto; Noriaki Sakakura; Takayuki Fukui; Simon Ito; Shunzo Hatooka; Hiroyuki Kuwano; Tetsuya Mitsudomi; Yukinori Sakao
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-13

Review 5.  Robotic surgery for lung resections-total port approach: advantages and disadvantages.

Authors:  Omar I Ramadan; Benjamin Wei; Robert J Cerfolio
Journal:  J Vis Surg       Date:  2017-03-08

Review 6.  Tips and tricks to decrease the duration of operation in robotic surgery for lung cancer.

Authors:  Omar I Ramadan; Robert J Cerfolio; Benjamin Wei
Journal:  J Vis Surg       Date:  2017-02-13

7.  Postoperative mortality is an inadequate quality indicator for lung cancer resection.

Authors:  Yinin Hu; Timothy L McMurry; Kristen M Wells; James M Isbell; George J Stukenborg; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2014-01-28       Impact factor: 4.330

8.  Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.

Authors:  Hiran C Fernando; Rodney J Landreneau; Sumithra J Mandrekar; Shauna L Hillman; Francis C Nichols; Bryan Meyers; Thomas A DiPetrillo; Dwight E Heron; David R Jones; Benedict D T Daly; Sandra L Starnes; Angelina Tan; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08-26       Impact factor: 5.209

9.  Poor survival for veterans with pathologic stage I non-small-cell lung cancer.

Authors:  Jamii B St Julien; Rhonda Pinkerman; Melinda C Aldrich; Heidi Chen; Stephen A Deppen; Carol Callaway-Lane; Pierre Massion; Joe B Putnam; Eric S Lambright; Jonathan C Nesbitt; Eric L Grogan
Journal:  Am J Surg       Date:  2012-08-18       Impact factor: 2.565

10.  The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes.

Authors:  Felix G Fernandez; Andrzej S Kosinski; William Burfeind; Bernard Park; Malcolm M DeCamp; Christopher Seder; Blair Marshall; Mitchell J Magee; Cameron D Wright; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2016-05-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.